Sanara Medtech Inc
NASDAQ:SMTI

Watchlist Manager
Sanara Medtech Inc Logo
Sanara Medtech Inc
NASDAQ:SMTI
Watchlist
Price: 23.63 USD 8.59%
Market Cap: 211.3m USD

Sanara Medtech Inc
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sanara Medtech Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Sanara Medtech Inc
NASDAQ:SMTI
Gross Profit
$94m
CAGR 3-Years
42%
CAGR 5-Years
49%
CAGR 10-Years
43%
Haemonetics Corp
NYSE:HAE
Gross Profit
$776.3m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
6%
ICU Medical Inc
NASDAQ:ICUI
Gross Profit
$846.3m
CAGR 3-Years
9%
CAGR 5-Years
13%
CAGR 10-Years
17%
Align Technology Inc
NASDAQ:ALGN
Gross Profit
$2.8B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
16%
Lantheus Holdings Inc
NASDAQ:LNTH
Gross Profit
$949.6m
CAGR 3-Years
26%
CAGR 5-Years
44%
CAGR 10-Years
22%
Merit Medical Systems Inc
NASDAQ:MMSI
Gross Profit
$715.9m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
12%
No Stocks Found

Sanara Medtech Inc
Glance View

Market Cap
211m USD
Industry
Health Care

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 63 full-time employees. The Company’s products include surgical wound care products, which includes CellerateRX Surgical Activated Collagen (Powder and Gel), and chronic wound care products, which include HYCOL Hydrolyzed Collagen (Powder and Gel), BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. The surgical wound care products are used in specialties including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, oncology, plastic/reconstructive, podiatric, urology and vascular. The chronic wound care products are used across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities, and wound care centers.

SMTI Intrinsic Value
37.67 USD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Sanara Medtech Inc's Gross Profit?
Gross Profit
94m USD

Based on the financial report for Sep 30, 2025, Sanara Medtech Inc's Gross Profit amounts to 94m USD.

What is Sanara Medtech Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
43%

Over the last year, the Gross Profit growth was 34%. The average annual Gross Profit growth rates for Sanara Medtech Inc have been 42% over the past three years , 49% over the past five years , and 43% over the past ten years .

Back to Top